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Abstract
Background: Human strongyloidiasis varies from a chronic but limited infection in normal hosts to hyperinfection in
patients treated with corticosteroids or with HTLV-1 co-infection. Regulatory T cells dampen immune responses to
infections. How human strongyloidiasis is controlled and how HTLV-1 infection affects this control are not clear. We
hypothesize that HTLV-1 leads to dissemination of Strongyloides stercoralis infection by augmenting regulatory T cell
numbers, which in turn down regulate the immune response to the parasite.
Objective: To measure peripheral blood T regulatory cells and Strongyloides stercoralis larval antigen-specific cytokine
responses in strongyloidiasis patients with or without HTLV-1 co-infection.
Methods: Peripheral blood mononuclear cells (PBMCs) were isolated from newly diagnosed strongyloidiasis patients with or
without HTLV-1 co-infection. Regulatory T cells were characterized by flow cytometry using intracellular staining for CD4,
CD25 and FoxP3. PBMCs were also cultured with and without Strongyloides larval antigens. Supernatants were analyzed for
IL-5 production.
Results: Patients with HTLV-1 and Strongyloides co-infection had higher parasite burdens. Eosinophil counts were decreased
in the HTLV-1 and Strongyloides co-infected subjects compared to strongyloidiasis-only patients (70.0 vs. 502.5 cells/mm
3,
p=0.09, Mann-Whitney test). The proportion of regulatory T cells was increased in HTLV-1 positive subjects co-infected with
strongyloidiasis compared to patients with only strongyloidiasis or asymptomatic HTLV-1 carriers (median=17.9% vs. 4.3%
vs. 5.9 p,0.05, One-way ANOVA). Strongyloides antigen-specific IL-5 responses were reduced in strongyloidiasis/HTLV-1 co-
infected patients (5.0 vs. 187.5 pg/ml, p=0.03, Mann-Whitney test). Reduced IL-5 responses and eosinophil counts were
inversely correlated to the number of CD4+CD25+FoxP3+ cells.
Conclusions: Regulatory T cell counts are increased in patients with HTLV-1 and Strongyloides stercoralis co-infection and
correlate with both low circulating eosinophil counts and reduced antigen-driven IL-5 production. These findings suggest a
role for regulatory T cells in susceptibility to Strongyloides hyperinfection.
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Introduction
Strongyloides stercoralis infects 60 million individuals in tropical and
subtropical areas of the world [1–3]. It is unique among helminths
in that it can complete its life cycle inside a single human host [4].
The clinical presentation of human strongyloidiasis varies with the
status of the host’s immunity [5]. Immunocompetent individuals
develop a chronic, asymptomatic or mildly symptomatic infection.
Patients treated with corticosteroids, cancer patients and persons
infected with the Human T-cell-lymphotropic virus 1 (HTLV-1),
may develop an accelerated form of infection termed hyperinfec-
tion, characterized by gastrointestinal and pulmonary hemor-
rhage, and secondary bacterial infections due to large numbers of
parasite larvae migrating from the gut through the lung [6–9].
Strongyloides hyperinfection has a high fatality rate [10].
Animal models have only provided limited understanding of how
the host controls S. stercoralis, because the parasite cannot complete
the lifecycle in mice [11]. Though murine models are not ideal for
www.plosntds.org 1 June 2009 | Volume 3 | Issue 6 | e456this particular parasite, careful studies have suggested a role for
innate and adaptative immune mechanisms of control [12]. The
innate response requires eosinophils, which kill the larvae [13]. The
cytokine IL-5 is essential for development and activation of
eosinophils [14]. The adaptive response involves specific antibody
production (including IgG and IgE), and granulocytes [15–17].
Neutrophils are more important than eosinophils in killing [15].
However, eosinophils are required to generate an optimal antibody
response [14], serving as antigen presenting cells [18]. Chemokines
attracting eosinophils (eotaxin) and granulocytes (IL-8) are also
needed to kill the larvae, presumably by attracting these
granulocytes to kill the parasites [19].
There are few studies on the human immune response to S.
stercoralis infection [7]. Since hyperinfection develops in transplant
and corticosteroid-treated patients, some thought that the cellular
immune response might play an important response in controlling
infection. HIV is a retrovirus that causes depletion of the cellular
immune response and acquired immunodeficiency syndrome
(AIDS). However, even with severe depletion of CD4 T cells,
AIDS patients control dissemination of S. stercoralis [20]. Thus,
factors other than the cellular immune response are likely more
important in control of strongyloidiasis.
HTLV-1 is another human retrovirus endemic in Japan, Africa,
the Caribbean and South America [8]. In contrast to patients with
AIDS, patients co-infected with S. stercoralis and HTLV-1
frequently develop S. stercoralis hyperinfection [9,10,21]. HTLV-1
and HIV share basic retroviral structures and modes of
transmission. Both HTLV-1 and HIV target CD4+ T lympho-
cytes, but, in contrast to HIV infection where T cells are killed,
HTLV-1 activates CD4+ T cells and induces CD4+ T cell
proliferation through up-regulation of interleukin-2 (IL-2) and its
receptor [8,22–24]. The cytokine profile of T cells isolated from
patients with HTLV-1 includes T helper 1 (Th1) cytokines (e.g.
IFN-c) as well as regulatory cytokines (e.g. IL-10 and TGFb) [25–
27]. Unlike HIV patients, patients with HTLV-1 are not
susceptible to intracellular opportunistic infections [8]. However,
disseminated strongyloidiasis is more common in HTLV-1-
infected patients than in HIV patients [9,21].
Regulatory T cells are increasingly recognized as playing a key
role in reducing injurious host inflammatory and immune
responses [28]. Regulatory T cells control the immune response
by different mechanisms: cell-to-cell contact, inhibitory cytokines
(e.g. TGF-b, IL-10) and by cytokine deprivation [29]. These cells
prevent an excessive immune response and bystander tissue
damage during the host response to infections [28]. In murine
models of Leishmania major infection, regulatory T cells prevent
complete elimination of the parasite, yet parasite persistence is
required for maintaining the protective immune response [30].
Some studies demonstrate that nematode infections (human and
mice) induce regulatory cell expansion [31]. Foxp3 expression
levels have been evaluated in patients with HTLV-1 associated
myelopathy and asymptomatic carriers with varied results [32,33].
Foxp3 levels inversely correlate with the rate at which cytotoxic T
cells kill HTLV-1 infected lymphocytes in an ex-vivo model [34].
Regulatory T cells have not been studied in HTLV-1 and S
stercoralis infected patients. We hypothesize that HTLV-I leads to
dissemination of Strongyloides stercoralis by augmenting regulatory T
cells (Treg), which in turn down regulate the immune response
against this parasite, allowing for the hyperinfection syndrome.
Materials and Methods
Study population and collection of clinical data
The Instituto de Medicina Tropical ‘Alexander von Humboldt’
at the Universidad Peruana Cayetano Heredia (IMT AvH -
UPCH) in Lima, Peru is a national referral center for the study of
HTLV-1 and its associated diseases. Patients with strongyloidiasis
are routinely tested for HTLV-1 infection. Between November
2005 and August 2007, all newly diagnosed subjects with
strongyloidiasis were invited to participate. Strongyloidiasis
diagnosis was confirmed by stool examination. All those with S.
stercoralis in stool were tested for HTLV-1 infection by Enzyme-
Linked Immuno Sorbent Assay (Ortho HTLVI/HTLVII Ab-
capture ELISA, Ortho-Clinical Diagnostics, USA) with confirma-
tory western blot analysis (INNO-LIA HTLVI/II Score, Innoge-
netics, Belgium). Consenting patients underwent further clinical
and laboratory evaluation, including complete blood count (CBC)
with differential, flow cytometry analysis and immunological
studies of peripheral blood mononuclear cells (PBMCs). Demo-
graphic and symptoms data were obtained from patient interviews
and reviews of clinical records. Stool and blood samples were
collected at the outpatient clinic at the time of enrollment. In
addition, asymptomatic HTLV-1 infected patients and healthy
HTLV-1 negative subjects were enrolled as controls.
Ethics
All participants signed a written informed consent form prior to
enrollment in the study. The Institutional Review Board (Comite ´
Institucional de E ´tica) of the Universidad Peruana Cayetano
Heredia in Lima, Peru ´ approved the study protocol and consent
forms.
Stool examination
Routine stool evaluation for ova and parasites included direct
examination, and spontaneous and fast sedimentation techniques.
Stools were examined for S. stercoralis using the Baermann
technique modified by Lumbreras [35]. S. stercoralis parasite load
was reported in a semi-quantitative scale as negative, 1+, 2+, 3+ or
Author Summary
Human strongyloidiasis varies from a mild, controlled
infection to a severe frequently fatal disseminated
infection depending on the hosts. Patients infected with
the retrovirus HTLV-1 have more frequent and more severe
forms of strongyloidiasis. It is not clear how human
strongyloidiasis is controlled by the immune system and
how HTLV-1 infection affects this control. We hypothesize
that HTLV-1 leads to dissemination of Strongyloides
stercoralis by augmenting regulatory T cell numbers,
which in turn down regulate the immune response to
the parasite. In our study, patients with HTLV-1 and
Strongyloides co-infection had higher parasite burdens
than patients with only strongyloidiasis. Eosinophils play
an essential role in control of strongyloidiasis in animal
models, and eosinophil counts were decreased in the
HTLV-1 and Strongyloides stercoralis co-infected subjects
compared to patients with only strongyloidiasis. The
proportion of T cells with a regulatory cell phenotype
was increased in HTLV-1 positive subjects co-infected with
strongyloidiasis compared to patients with only strongy-
loidiasis. IL-5 is a key host molecule in stimulating
eosinophil production and activation, and Strongyloides
stercoralis antigen-specific IL-5 responses were reduced in
strongyloidiasis/HTLV-1 co-infected patients. Reduced IL-5
responses and eosinophil counts were inversely correlated
to the number of regulatory T cells. These findings suggest
a role for regulatory T cells in susceptibility to Strongyloides
hyperinfection.
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by personnel who were blinded to the HTLV-1 status of the
participant.
Flow cytometry
PBMCs were isolated from heparinized blood by density gradient
centrifugation (BD Vacutainer CPT Cell Preparation Tube with
Sodium Heparin, NJ). Regulatory cells were defined by staining for
CD4, CD25, and FoxP3. PBMCs were first stained using Cy-5
conjugated anti-CD4 and phycoerythrine (PE)-conjugated anti-
CD25 monoclonalantibodies (BD Biosciences, SanJose, California,
USA). After fixing and permeabilizing, the cells were then stained
for intracellular FoxP3 using a fluorescein-isothiocyanate (FITC)-
conjugated anti-FoxP3 monoclonal antibody (eBiosciences, San
Diego, California, USA). Cells were analyzed using a FACScalibur
flow cytometer (Beckton Dickinson, Franklin Lakes, New Jersey,
USA). Regulatory T cells were identified as CD25+ and FoxP3+
cellsamongCD4+ cellswithinthe lymphocyte gate.AbsoluteCD4+
cell counts were performed using a 4 color single platform staining
of whole blood cells (anti CD3-FITC, CD4-PE, CD45 PerCP and
CD8 APC). Flow cytometry analysis used FlowJo software (V.8.5
Tree Star, Ashland, Oregon, USA).
Antigen-specific cytokine responses to Strongyloides
stercoralis antigen
S. stercoralis third-stage larvae (L3) were obtained and cleaned as
previously described [36]. Briefly, feces from an infected dog was
mixed with bone charcoal and cultured at 25uC for 7 days. The L3
were obtained from the fecal-charcoal culture by the use of a
Baermann apparatus and allowed to settle in a tube for
30 minutes. The supernatant was then removed and the pellet
of L3 was resuspended with an equal volume of 2% liquid low-
gelling temperature agar (Sigma Chemical Co., St. Louis, MO,
USA) at 37uC. The worm-agar mix was allowed to solidify in the
center of a Petri dish and then covered with invertebrate saline.
The worms were allowed to migrate out of the solidified agar
(leaving most of the bacteria and fecal debris behind) at 37uC for
1 hour. The saline with the clean worms was then centrifuged to
pellet the worms. The L3 pellet was frozen at 220uC until needed.
Crude antigen was obtained by sonication of L3 larvae and
centrifugation, supernatant was collected and protein concentra-
tion was determined by colorimetric Bradford assay. PBMCs were
cultured in RPMI-1640, 10% Fetal Bovine Serum antibiotic
supplemented media (37uCi n5 %C O 2) for 72 hours in the
presence or absence of 2-ug/ml crude infective stage S. stercoralis
larvae (L3) antigen. PBMCs were adjusted to a final concentration
of 1610
6 cells/ml. Supernatants were collected and stored at
280uC until cytokine analysis.Interleukin 5 (IL-5) was measured
by enzyme-linked immuno sorbent assay on the cell culture
supernatant following manufacturer’s instructions (BD OptEIA,
BD Biosciences, San Diego, California, USA).
Measurement of HTLV-1 proviral load
HTLV-1 proviral load in PBMCs was quantified in the
strongyloidiasis and HTLV-1 co-infected patients. HTLV-1
proviral load was quantified using a real-time SYBR Green
PCR method, as described previously [37].
Data analysis
We compared symptoms and parasite load between patients
with and without HTLV-1 by Chi square test. Blood results
including regulatory T cell numbers and proportions were
compared by ANOVA. The IL-5 responses to antigen stimulation
were compared by Mann-Whitney U test. The correlation
between the IL-5 responses and regulatory T cells were compared
by Spearman’s rank test.
Results
A total of 69 subjects were enrolled in the study. Forty-three
patients were identified as infected with S. stercoralis. Among them,
3 were HIV positive and excluded from further analysis. Of the 40
remaining S. stercoralis patients, 27 were infected with S. stercoralis
alone, and 13 were co-infected with S. stercoralis and HTLV-1.
Controls included 17 healthy subjects and 9 patients with HTLV-1
with stools negative for S. stercoralis.
Demographics
Demographic data are presented in Table 1. The median age
for all patients was 42.0 years (range 22 to 77). Patients with co-
Table 1. Demographics and frequency of clinical signs and symptoms of strongyloidiasis patients with and without HTLV-1 co-
infection.
Characteristic HTLV-1 carriers Strongyloides+HTLV-12 Strongyloides+/HTLV-1+ p
(n=9) (n=27) (n=13)
Gender (M/F) 7/2 15/12 7/6
Age (years) 40.0 39.0 45.0
Diarrhea (%) 0/9 16/26 (62) 7/13 (54) 0.65
Constipation (%) 0/9 10/26 (38) 5/13 (38) 1.00
Nausea/Vomiting (%) 0/9 7/26 (27) 8/9 (89) 0.001
*
Abdominal Pain (%) 0/9 9/26 (35) 6/9 (67) 0.09
Abd. Distension (%) 0/9 10/26 (38) 3/9 (33) 0.78
Flatulence (%) 0/9 11/26 (42) 6/9 (67) 0.21
Weight loss (%) 0/9 10/26 (38) 5/11 (45) 0.69
Clinical data was obtained from newly diagnosed patients with strongyloidiasis by stool modified Baermann sedimentation method and tested for HTLV-1 co-infection.
Age and gender were similar among strongyloidiasis patients with or without HTLV-1 co-infection. Gastrointestinal signs and symptoms were more frequently reported
among HTLV-1 co-infected patients. Table shows proportion of patients reporting symptoms. Frequencies were compared between S. stercoralis groups by Chi square
test, *=p,0.05 (Lima, Peru).
doi:10.1371/journal.pntd.0000456.t001
Regulatory T Cells in HTLV-1/Strongyloidiasis
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vs. 39.0 years. p=0.36). Gender distribution was similar for both
groups, with 55% male and 45% female. Patients were originally
from Andean, Coastal, and Jungle regions in decreasing order of
frequency for both groups. Most patients had visited the jungle
within three months of onset of gastrointestinal symptoms.
Symptoms
Abdominal pain, diarrhea, flatulence, nausea, vomiting, and
increasing abdominal girth were the most common complaints in
S. stercoralis groups, with over 50% of patients affected. Patients
with S. stercoralis and HTLV-1 co-infection reported more
symptoms than those only infected with S. stercoralis (Table 1).
Stool analysis
S. stercoralis and HTLV-1 co-infected patients showed more
parasites in stool samples compared with patients infected with S.
stercoralis only. A high parasite burden (3+ or 4+ larvae) was noted
in 10 (83%) of twelve of the co-infected patients. Conversely,
patients with just S. stercoralis had a low burden of disease (84%
Figure 1. Patients with strongyloidiasis and HTLV-1 co-infection (n=12) had more Strongyloides stercoralis larvae found in stool
when compared to strongyloidiasis-only patients (n=25). A semi-quantitative measure of Strongyloides stercoralis parasite load was
determined at the time of diagnosis according to the number of larvae observed in stool sediment after Baermann concentration (range from1+ to
4+). Parasite load determination was made before the HTLV-1 status was known. HTLV-1 carriers had higher parasite loads (3+ and 4+) when
compared to the non HTLV-1 group (10 out of 12 vs. 4 out of 25 respectively; p,0.001, Chi square test, Lima, Peru).
doi:10.1371/journal.pntd.0000456.g001
Table 2. Blood analysis, flow cytometry and interleukin-5 responses to Strongyloides stercoralis larval antigens A peripheral blood
sample was obtained at enrollment from all strongyloidiasis patients.
Characteristic Healthy Controls HTLV-1 carrier Strongyloidiasis+HTLV-12 Strongyloidiasis+HTLV-1+ p
(n=17) (n=9) (n=27) (n=13)
Hemoglobin (g/dl) - 13.8 14.1 12.80 0.11
Hematocrit (%) - 41 42 38 0.054
WBC (cells/mm
3) - 6200 7500 7000 0.19
Neutrophils (cells/mm
3) - 4745 4564 3900 0.69
Eosinophil % - 1 7 4 0.02*
Eosinophils (cells/mm
3) - 47 511 200 0.01*
CD4 count (cells/mm
3) 721 1166 819 962 0.07
Regulatory T-cell (%) 7.1 5.9% 4.3% 17.9% ,0.0001*
Regulatory T-cell count 53 69 41 233 ,0.0001*
Samples were analyzed before HTLV-1 status was known. Numbers represent median of all parameters analyzed. Complete peripheral blood cell count showed lower
hemoglobin and hematocrit levels in the HTLV-1 co-infected group. White blood cell, neutrophil, eosinophil, and lymphocyte proportions were not significantly
different among groups, although a tendency to lower absolute eosinophil count was observed in the HTLV-1 infected group. Regulatory T cells were significantly
increased in patients with strongyloidiasis and HTLV-1 co-infection (*=p,0.05, One way ANOVA, Lima, Peru).
doi:10.1371/journal.pntd.0000456.t002
Regulatory T Cells in HTLV-1/Strongyloidiasis
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parasites were found in the stool of 51% of all patients, including
Blastocystis hominis (39%), Trichuris trichiura (10%), hookworms (8%),
Giardia lamblia (5%), and Ascaris lumbricoides (2.5%).
Blood analysis
Median hemoglobin and hematocrit were lower in the S.
stercoralis/HTLV-1 co-infected group compared to HTLV-1
asymptomatic carriers and S. stercoralis-only patients (12.8 versus
13.8 versus 14.1 g/dl, p=0.11; and 38 versus 41 and 42%
p=0.054 One way ANOVA). Total white blood cell counts and
neutrophil counts did not differ significantly among the groups.
HTLV-1 asymtpmatic carriers did not show increased eosinophil
numbers. Among S. stercoralis infected subjects there was a trend
towards lower median eosinophils in patients co-infected with
HTLV-1 (4% versus 7%; 200 versus 511 cells/mm
3 (Table 2).
Flow cytometry analysis
The median CD4+ and CD8+ T-cell count were similar in
strongyloidiasis patients regardless of their HTLV-1 status
Figure 2. Flow cytometry analysis showing increased proportions of CD4+CD25hi T cells and CD4+CD25+FoxP3+ regulatory T cells
in peripheral blood of patients with strongyloidiasis and HTLV-1 co-infection. Representative flow cytometry analysis of peripheral blood
mononuclear cells comparing a patient with strongyloidiasis without HTLV-1 co-infection (left) to strongylioidiasis/HTLV-1 co-infected patient (right).
Upper figures show CD4 and CD25 staining of cells within the lymphocyte gate. Note population of CD4+CD25hi cells in the HTLV-1 co-infected
patient suggesting regulatory T cell phenotype. Lower figures show CD4+ lymphocytes stained with CD25 and intracellular staining with FoxP3
confirming that CD4+CD25hi cells are indeed FoxP3+ (regulatory T cells).
doi:10.1371/journal.pntd.0000456.g002
Regulatory T Cells in HTLV-1/Strongyloidiasis
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expanded CD4+CD25
hi lymphocyte population. Furthermore,
the proportion of CD4+ T-cells with regulatory T-cell
phenotype (CD4+CD25+FoxP3+) was significantly increased in
the HTLV-1 co-infected patients (median proportion of CD4+
T-cells that were CD25+FoxP3+: 17.9%) when compared to all
other groups (p,0.0001 One way ANOVA, Table 2, Figures 2
and 3).
Interleukin-5 responses to Strongyloides antigen
PBMC’s from strongyloidiasis patients produced IL-5 in
response to S. stercoralis infective stage larvae crude antigen.
However, the IL-5 response was reduced in S. stercoralis and
HTLV-1 co-infected patients (10 vs 299 pg/ml respectively,
p=0.0004, Mann-Whitney test, Figure 4). An inverse correlation
was observed between the number of regulatory T-cells and IL-5
cytokine responses (Spearman r=20.39, p=0.03, Figure 5).
Characteristics of the HTLV-1 proviral load
Proviral load data were available for 9 of the 13 HTLV-1 co-
infected patients (mean 1566 copies/10
4 PBMCs; ranged from
1442 to 5460). These patients had a significantly higher mean
proviral load than did asymptomatic carriers (mean 561 copies/
10
4 PBMCs; range 1 to 4773) and were similar to HTLV-1-
associated myelopathy patients (mean 1783 copies/10
4 PBMCs;
range 142 to 8641), as reported elsewhere [37].
Discussion
In thisstudy, we demonstrate that immunocompetent patientswith
S. stercoralis infection have lower worm burdens and higher eosinophil
counts compared to patients who are co-infected with HTLV-1 and
normal controls. The immunocompetent patients also produce IL-5
inresponsetostimulationwithS.stercoralislarvalantigens. By contrast,
patients with S. stercoralis and HTLV-1 co-infection have reduced IL-5
responses to parasite antigens, which may lead to decreased
eosinophil count. We also noted increased proportions of
CD4+CD25+FoxP3+ regulatory T cells in patients with S. stercoralis
and HTLV-1 co-infection compared to either normal controls or
patients infected with either HTLV-1 or S. stercoralis only. The
proportion of lymphocytes expressing this phenotype was inversely
correlated with antigen-driven IL-5 responses. Thus, augmented
regulatory T cell function may explain the defective eosinophil
numbers in S.stercoralis patients co-infected with HTLV-1.
HTLV-1 is an important risk factor for Strongyloides dissemina-
tion, but the mechanisms are poorly understood [38]. Previous
studies have demonstrated lower eosinophil counts, decreased
production of IL-5, and increased production of interferon gamma
in patients with S. stercoralis and HTLV-1 co-infection [10].
IL-5 is a key growth and activation factor for eosinophils [39].
Eosinophils play a key role in clearance of other helminths larvae
[40]. Several mechanisms may be involved including direct
cytotoxicity and antibody dependant cellular cytotoxicity [40].
We reasoned that regulatory T cells might be responsible for the
reduced IL-5 and eosinophil responses in S. stercoralis and HTLV-1
co-infected patients. Indeed, the proportion of CD4+ cells that were
CD25+FoxP3+ was dramatically increased in patients with S.
stercoralis and HTLV-1 co-infection. These levels are higher than
have previously been described in humans. Furthermore, those with
increased proportions of CD25+FoxP3+ cells had decreased antigen-
driven production of IL-5 and lower eosinophil counts. Since HTLV-
1 can augment expression of CD25, we also re-analyzed the data
without including CD25 expression in the definition of regulatory
cells(i.e.CD4+FoxP3+).We also performed an analysisusing CD127
expression (low or negative) to define regulatory cells. In all of these
analyses, the results were similar. Taken together, these data strongly
Figure 3. Increased proportions of regulatory T cells in strongyloidiasis/HTLV-1 co-infected patients. Comparison of regulatory T cell
proportions (CD25+FoxP3+ among CD4+ T-cells) between healthy controls (blue, n=17), patients with strongyloidiasis without HTLV-1 infection (red,
n=27), HTLV-1 asymptomatic carriers (orange, n=9) and strongyloidiasis/HTLV-1 co-infected patients (green, n=13). Co-infected patients had a
significant increase of regulatory T cells compared to non-HTLV-1 patients. (*=P,0.05, One-way ANOVA). Lima, Peru.
doi:10.1371/journal.pntd.0000456.g003
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which influences the function of eosinophils.
Pro-viral loads were also elevated in the strongyloidiasis and
HTLV-1 co-infected patients, similar to levels increased for other
HTLV-1 associated diseases like HTLV-1 associated myelopathy.
This suggests that this expanded regulatory T-cell population may
be induced by HTLV-1-S. stercoralis co-infection or as a response to
the proinflammatory effects of these infections. Further studies are
Figure 5. Increased numbers of regulatory T cells correlates with reduced IL-5 responses to Strongyloides stercoralis larval antigens.
Patients with higher regulatory T cell numbers showed lower IL-5 responses to Strongyloides stercoralis infective-stage crude antigen. An inverse
correlation was determined by Sperman non-parametric correlation analysis (Spearman r=20.38, p=0.03).
doi:10.1371/journal.pntd.0000456.g005
Figure 4. IL-5 responses to larval Strongyloides stercoralis antigens are decreased in patients with strongyloidiasis and HTLV-1 co-
infection (n=13) compared to HTLV-1 negative subjects with strongyloidiasis (n=27). Peripheral blood mononuclear cells from newly
diagnosed strongyloidiasis patients were cultured with or without Strongyloides stercoralis infective-stage larval antigen. Culture supernatants were
analyzed for IL-5 production. Patients with HTLV-1 co-infection had significantly decreased IL-5 responses (* p=0.0004, Mann Whitney test).
doi:10.1371/journal.pntd.0000456.g004
Regulatory T Cells in HTLV-1/Strongyloidiasis
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infection of the Treg cells.
In summary, we have demonstrated that patients with S.
stercoralis and HTLV-1 co-infection do not control S. stercoralis
infection as well as patients with S. stercoralis only as indicated by
the increase in the number of larvae in stool samples. This defect
in immune host response is associated with lower eosinophil counts
and decreased antigen-driven production of IL-5. This reduced
response is inversely correlated with the proportion of CD4 cells,
which are CD4+CD25+FoxP3+, suggesting a role for these cells in
blunting antigen-driven protective responses. Additional data is
needed to determine whether regulatory T cells are increased
because they are HTLV-1 infected or as a response to parasite
infection, and to explore mechanisms for suppression of eosinophil
counts and function.
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